Table 2. Patient background.
| Item | Sample A | Sample B | P value |
|---|---|---|---|
| Sample | |||
| Size | 85 | 41 | |
| Sex (male/female) (n) | 56/29 | 21/20 | |
| Age (years) | 68.7±16.2 (29 to 89) | 68.4±8.7 (52 to 86) | 0.511 |
| Physique | |||
| Body weight (kg) | 63.4±9.1 (46.0 to 104.0) | 64.4±8.5 (50.0 to 85.0) | 0.576 |
| Body thickness (cm) | 22.2±2.2 (16.0 to 29.3) | 22.4±2.1 (16.7 to 26.4) | 0.650 |
| Body width (cm) | 30.6±2.2 (24.6 to 36.8) | 30.6±2.3 (25.8 to 35.0) | 0.878 |
| Liver disease (n) | |||
| Chronic viral hepatitis (type B and/or C) | 16 | 11 | |
| Liver cirrhosis (hepatitis B and/or C) | 35 | 19 | |
| Alcoholic liver disease | 13 | 7 | |
| Nonalcoholic fatty liver disease | 4 | 2 | |
| Primary biliary cholangitis | 1 | 0 | |
| Normality | 16 | 2 | |
| Mass (HCC/metastasis) (n) | 50/6 | 32/0 | |
| Liver function test | |||
| ALBI score | −2.46±0.57 (−3.30 to −0.92) | −2.55±0.44 (−3.41 to −1.43) | 0.353 |
| ALBI grade (Grade 1/Grade 2/Grade 3) (n) | 43/35/7 | 20/21/0 | |
| Classic liver function data | |||
| Albumin (g/dL) | 3.78±0.60 (2.40 to 4.80) | 3.85±0.51 (2.60 to 4.80) | 0.542 |
| Total bilirubin (mg/dL) | 0.95±0.64 (0.20 to 3.90) | 0.78±0.34 (0.30 to 2.00) | 0.114 |
| Direct bilirubin (mg/dL) | 0.40±0.48 (0.06 to 3.22) | 0.35±0.45 (0.07 to 3.00) | 0.575 |
All data except those indicated as n represent mean ± standard deviation (minimum to maximum). P, probability; n, number of patients; HCC, hepatocellular carcinoma; ALBI, albumin-bilirubin.